Lv1
32 积分 2025-12-01 加入
Guidelines for the treatment of psoriasis with biologic agents in China （2021）
16天前
已完结
Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial
21天前
已完结
糖尿病患者合并心血管疾病诊治专家共识(2026年版)
23天前
已完结
KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRASG12D-mutant pancreatic cancer: a phase 1b/2 trial
1个月前
已完结
The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study
2个月前
已完结
Use of systemic and biological therapy in patients with moderate-to-severe psoriasis
2个月前
已完结
A multicenter, randomized, double-blinded, placebo-controlled, phase Ⅲ study evaluating the efficacy and safety of Xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis
2个月前
已完结
Comparison of Secukinumab and Ixekizumab in psoriasis: a real‐life cohort study on the efficacy and drug survival of 445 patients
2个月前
已完结
Ivarmacitinib ointment in treatment of adults with mild-to-moderate atopic dermatitis: phase III of a randomized double-blind placebo-controlled phase II/III clinical trial
3个月前
已完结
血脂报告单规范化中国专家指导建议
3个月前
已完结
皖公网安备34019202002308
